Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec vs insulin glargine in insulin-naïve type 2 diabetes (China)
CTR20130105Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started May 2014; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20130105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130105.